Inhibition of the recovery from potentially lethal damage by lonidamine
1984

Lonidamine Inhibits Cell Recovery from Damage

publication Evidence: moderate

Author Information

Author(s): G.M. Hahn, I. van Kersen, B. Silvestrini

Primary Institution: Stanford University Medical Center

Hypothesis

Does lonidamine inhibit the recovery of cells from potentially lethal damage after exposure to radiation and certain drugs?

Conclusion

Lonidamine effectively inhibits the recovery of cells from potentially lethal damage caused by X-rays, methyl methane sulfonate, and bleomycin when administered before and after exposure.

Supporting Evidence

  • Lonidamine inhibits recovery from potentially lethal damage when present before and after exposure to damaging agents.
  • Recovery from damage is completely inhibited at a dose of 50 mg/l of lonidamine.
  • Lonidamine's effects were observed in cells exposed to X-rays, methyl methane sulfonate, and bleomycin.

Takeaway

Lonidamine is a drug that can stop cells from healing after they get hurt by radiation or certain medicines, which might help in cancer treatment.

Methodology

Chinese hamster cells were treated with X-rays, methyl methane sulfonate, or bleomycin, and the effect of lonidamine on their recovery was tested by measuring colony formation.

Limitations

The study does not provide data on how lonidamine works to inhibit recovery.

Participant Demographics

Chinese hamster cells were used in the experiments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication